2022 HTRS Mentored Research Award (MRA)
 for Gene Therapy in Hemophilia A

The application window for the 2022 MRA for Gene Therapy in Hemophilia A Program is closed.  

The HTRS Mentored Research Award (MRA) for Gene Therapy in Hemophilia A provides a grant for a qualified fellow or junior attending/junior faculty (MDs, DOs, MBBSs, or the equivalent) pursuing clinical, translational, or basic science research projects in Gene Therapy in Hemophilia A, under the guidance of an experienced mentor. 

Goals of the HTRS MRA Program:

  • Increase the number of skilled physician-scientists in the U.S. medical workforce dedicated to long-term research careers in classical hematology
  • Support innovative research by pairing talented young physician-scientists with experienced mentors, many of whom are recognized leaders in U.S. clinical and/or basic science research in hemostasis and thrombosis
  • Provide trainees and junior faculty an accessible “on-ramp” into the NIH research pipeline by funding initial research programs that can spark and support K-award applications

 Current HTRS Mentored Research Award (MRA) for Gene Therapy
 in  Hemophilia A Recipient


Seema Patel, PhD
Emory University
Supported by an independent medical training grant from Spark Therapeutics.